Charlotte's Web (Cannabis)[edit | edit source]

Overview[edit | edit source]

Charlotte's Web is a high-cannabidiol (CBD), low-tetrahydrocannabinol (THC) Cannabis strain marketed as a dietary supplement under federal law of the United States. It is produced by the Stanley brothers in Colorado. Named after Charlotte Figi, a child with severe epilepsy whose condition significantly improved after using this cannabis strain, Charlotte's Web is specifically cultivated for its high CBD and low THC content.

Background[edit | edit source]

Charlotte's Web was developed in 2011 by the Stanley brothers (Joel, Jesse, Jon, Jordan, Jared, and Josh) through crossbreeding a strain of marijuana with industrial hemp. This process created a plant with a rich concentration of CBD, the compound responsible for many of the medical benefits of cannabis, but with minimal psychoactive effects due to the strain's low THC content.

Medical Applications[edit | edit source]

Charlotte's Web is primarily known for its potential benefits in treating severe forms of epilepsy, such as Dravet syndrome and Lennox-Gastaut syndrome. The strain's high CBD content has been reported to reduce the frequency and intensity of seizures in some patients, with Charlotte Figi's case being one of the most publicized instances. Beyond epilepsy, Charlotte's Web is also being explored for its potential to alleviate symptoms associated with:

Chronic pain
Anxiety
Depression
Inflammatory diseases

Legal Status[edit | edit source]

The legal status of Charlotte's Web and other CBD-rich strains varies by jurisdiction. In the United States, hemp-derived CBD products containing less than 0.3% THC are legal at the federal level but may face restrictions in certain states. It is essential for consumers to check their local laws before purchasing or using CBD products.

Research and Development[edit | edit source]

Ongoing research into CBD and strains like Charlotte's Web focuses on understanding their efficacy, mechanisms of action, and potential applications in medical treatment. Clinical trials and scientific studies are essential for validating anecdotal evidence and for the potential FDA approval of cannabis-based therapies.

Cultivation and Availability[edit | edit source]

Charlotte's Web is cultivated under strict quality control measures to ensure consistent CBD levels and minimal THC content. The strain is available in various forms, including oils, capsules, and topical products, to accommodate different methods of administration.

Cannabis sativa plant, from which Charlotte's Web is derived.

Challenges and Controversies[edit | edit source]

While Charlotte's Web has gained significant attention for its potential health benefits, challenges remain regarding regulation, standardization of dosing, and the need for more comprehensive scientific research to fully understand its effects and safety profile.

References[edit | edit source]

External Links[edit | edit source]

Charlotte's Web official website

Charlotte's web (cannabis) Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.